Showing 1 - 10 of 1,776
Many countries with national health care providers and health insurances regulate the market for pharmaceuticals to … (no. of firms) suggests a significant but small negative correlation with prices. -- pharmaceuticals ; prices ; co …
Persistent link: https://www.econbiz.de/10009522774
Access to medicines at prices patients can afford has been a recurrent concern for the global community ever since the Agreement on Trade Related Aspects of Intellectual Property (TRIPS) was adopted in 1995 as one of the agreements under the World Trade Organization (WTO). In 2001, WTO Members...
Persistent link: https://www.econbiz.de/10012316008
This paper studies how gifts - monetary or in-kind payments - from drug firms to physicians in the US affect … prescriptions and payments with causal inference and machine learning methods. We find that payments cause physicians to prescribe … more brand drugs, resulting in a cost increase of $30 per dollar received. Responses differ widely across physicians, and …
Persistent link: https://www.econbiz.de/10014249570
In a complex economy, production is vertical and crosses jurisdictional lines. Goods are often produced by a global or national firm upstream and improved or distributed by local firms downstream. In this context, heightened products liability may have unintended consequences for consumer...
Persistent link: https://www.econbiz.de/10013056589
Persistent link: https://www.econbiz.de/10011815606
In a complex economy, production is vertical and crosses jurisdictional lines. Goods are often produced by a global or national firm upstream and improved or distributed by local firms downstream. In this context, heightened products liability may have unintended consequences for consumer...
Persistent link: https://www.econbiz.de/10012458659
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...
Persistent link: https://www.econbiz.de/10013068052
Fiercely contested before, during, and after its passage, the 2010 Patient Protection and Affordable Care Act (ACA) is beginning to restructure the U.S. healthcare market. This article describes the history of healthcare reform initiatives in the United States, analyzes the policy context in...
Persistent link: https://www.econbiz.de/10014151937
Purpose: US policy makers have been looking at various ways to curb rising health care costs in USA, including ways to promote the use of generic drugs in lieu of brand drugs. In this broader context, the implementation of Patient Protection and Affordable Care Act (ACA) in December 2013 will...
Persistent link: https://www.econbiz.de/10014036939
Pharmaceutical spending in many other countries has had a steep increase in the last decade. The Portuguese Government has adopted several measures to reduce pharmaceutical expenditure growth, ranging from increased co-payments to price decreases determined administratively. Promotion of generic...
Persistent link: https://www.econbiz.de/10014209702